Brainify.AI

The AI engine Fit Assessment

Beta

The company will be attending ViVE 2025 Event

Blurb

AI EEG biomarker platform improves the likelihood of new drug approval and reduces R&D costs. TEDx - https://youtu.be/32YgTYMhT4o

HQ Location

New York (United States)

Founded

2021

Employees

11 - 50

Total funding raised

$1.60M

Last Funding Event

Pre-Seed, $1.00M, January 10, 2023

Smart insights

  • Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
  • Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
  • 6m headcount growth: 25%
  • 1Y headcount growth: 94%
  • Headcount-to-last-round ratio: 5.3 employees/$M

Developer of a neuroscience platform that aims to revolutionize brain health and predict patients' treatment outcomes before the treatment begins. The company's platform focuses on increasing treatment efficacy and diagnostic accuracy for neurodegenerative disorders, psychiatry, and neurology, its data engine integrates diverse brain data to build a Foundational EEG (Electroencephalogram) model, enabling clinicians to have efficient outcomes by lowering the risk of patient death by suicide and patients to receive the best medication.